Gland Pharma Limited — Giving guarantees/indemnity/ becoming a surety for third party

Gland Pharma Limited has informed the stock exchanges that it has issued a corporate guarantee on behalf of its wholly-owned subsidiary, Phixen SAS. This move means Gland is acting as a surety for the subsidiary's obligations, effectively vouching for its financial commitments. Such guarantees are typically issued to secure loans or credit facilities for the subsidiary's operations.

This development is significant for investors as it increases the parent company's financial exposure. While the subsidiary is wholly owned, the guarantee could impact Gland's credit rating and future borrowing capacity. It signals a commitment to supporting the subsidiary's growth but also introduces an additional layer of financial risk that investors should monitor closely.

Investors should watch for updates on the specific amount of the guarantee and how it might affect Gland's overall debt profile. Understanding the scale of this exposure is crucial for assessing the financial health and risk profile of the company.